Haemophilia trials in Saudi Arabia

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

  Where

  Dammam, Riyadh

  Age

  1 year to 11 years

  People

  85 worldwide

  Run by

  Sanofi

  See details and how to joinNCT07285460 · EU 2025-521858-42-00
• Phase 3Taking people
  A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

  Where

  Dammam

  Age

  1 year to 17 years

  People

  100 worldwide

  Run by

  Pfizer

  See details and how to joinNCT05611801 · EU 2022-500495-65-00
• Phase 3Taking people
  Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

  Where

  Riyadh

  Age

  18 years and over

  People

  173 worldwide

  Run by

  Pfizer

  See details and how to joinNCT05568719
• Phase 3Taking people
  Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)

  Where

  Riyadh

  Age

  18 years and over

  People

  35 worldwide

  Run by

  CSL Behring

  See details and how to joinNCT06003387 · EU 2023-509590-23-00